John Farnam
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About John Farnam
John Farnam was last confirmed as COO at Kura Oncology, Inc. (KURA) in a filing dated April 28, 2020. The proxy statement of Kura Oncology, Inc. reports total compensation of $2,163,376 for John Farnam in fiscal 2019, including a base salary of $236,169. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2020-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Kura Oncology, Inc. (KURA) | Former Chief Operating Officer | $236,169 | $2,163,376 |
| 2018 | Kura Oncology, Inc. (KURA) | Former Chief Operating Officer | $177,500 | $1,717,340 |
Recent activity
No call appearances or filed executive changes recorded yet.